Calsibon Soft Capsule (Calcitriol)

Adult dose

Patients before the dialysis stage: Initiate with a starting dose of 0.25 ㎍ daily, which may be increased to 0.5 ㎍ daily if necessary. Renal osteodystrophy (dialysis patients): Initial dose is 0.25 ㎍ daily, and if serum calcium levels are within the normal range or slightly lowered, 0.25 ㎍ should be administered every other day, with possible increases of 0.25 ㎍ every 2-4 weeks. Most patients show effectiveness at a daily dose of 0.5-1.0 ㎍.

Child dose

Patients before the dialysis stage: For children aged 36 months and older, initiate with a starting dose of calcitriol at 0.25 ㎍ daily, which may be increased to 0.5 ㎍ daily if necessary. For children under 36 months

This medication should not be used in patients with hypercalcemia or hypercalciuria causing calcium stones. Additionally, individuals allergic to this medication or similar drugs should not take it. Pregnant or breastfeeding women should exercise special caution when using this medication and should do so only after consulting a physician. There is limited experience with use in young children or pediatric patients receiving dialysis, so caution is advised. This drug is an active form of vitamin D, and overdose can lead to symptoms of hypercalcemia, which can cause nausea, vomiting, headache, lethargy, and dehydration if aggravated. Regular blood tests should be conducted to monitor calcium levels during use. It is important to maintain an adequate calcium intake while taking this medicine and to avoid excessive calcium supplementation. Additionally, since interactions with other medications may occur, especially with vitamin D preparations, calcium supplements, diuretics, and digitalis, consultation with a physician or pharmacist is essential when taking these medications together. Elderly patients or those with impaired kidney function should adjust dosing and be monitored frequently, and in the case of an overdose, immediate cessation of the medication and notification to healthcare personnel is necessary. Store this medication in a cool place below 25 degrees Celsius, protected from light and moisture, and out of reach of children.

Serious side effects

Hives, severe swelling (edema), severe rash accompanied by fever, skin desquamation, pain in oral/ocular mucosa, severe allergic reaction, severe skin abnormal reaction, difficulty breathing or respiratory distress, asthma attack, respiratory abnormalities accompanied by cough and fever, respiratory issues, jaundice (yellowing of skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and severe headache, lightning headache, seizure, consciousness confusion, visual disturbances

Mild side effects

• Nausea
• diarrhea
• appetite loss
• constipation
• vomiting
• gastrointestinal discomfort
• abdominal pain
• thirst
• abdominal cramps
• atonic intestinal obstruction

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is best stored at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy for a longer period.

Appearance

A milky, oval-shaped soft capsule containing a colorless or transparent emulsion.

Package unit

30 capsules per bottle, 300 capsules per bottle